Hereditary angioedema gene therapy hope
A CRISPR-based genome therapy has shown promising results for patients with a rare genetic swelling disorder
About Alison Emm
This author has yet to write their bio.Meanwhile lets just say that we are proud Alison Emm contributed a whooping 12 entries.
Entries by Alison Emm
BRCA testing for people with Jewish ancestry
1st March 2024 in Genomics in practice /by Alison EmmNHS England has launched a testing service for people with Jewish ancestry to see if they carry a potentially harmful BRCA variant
NICE recommendations broaden patient access to cancer drug olaparib
9th February 2024 in Genomics in practice /by Alison EmmThe use of the targeted therapy has been expanded to include certain types of breast, prostate, ovarian, fallopian tube and primary peritoneal cancers
Clinical trials show promise for first ‘gene silencing’ treatment for Alzheimer’s disease
26th January 2024 in Research /by Alison EmmA new RNA-based therapy for Alzheimer’s disease that’s in clinical trial phase could be the first of its kind to use ‘gene silencing’ for the condition
Casgevy – the first CRISPR therapy
1st December 2023 in Genomics in practice /by Alison EmmThe UK has approved a new type of gene therapy for the blood disorders sickle cell disease and beta-thalassaemia, a world-first using CRISPR technology
Gene therapy – a new approach for paediatric hearing loss
3rd November 2023 in Research /by Alison EmmA new gene therapy is being trialled for children with a rare form of deafness caused by variants in the OTOF gene
Genomics England to launch the Generation Study
20th October 2023 in Research /by Alison EmmThis winter sees the start of the Generation Study, which will explore the benefits and challenges of sequencing the genomes of 100,000 newborns
Sequencing the Y chromosome – five things we now know
22nd September 2023 in Research /by Alison EmmAfter years of research, a fully annotated sequence of the human Y chromosome has been published. We celebrate this breakthrough with a few key facts
The role of genes in susceptibility to skin cancer
8th September 2023 in Research /by Alison EmmThe UK is no sun-drenched paradise, but skin cancer is common among the population. As summer ends, we consider new research that may offer an explanation as to why
How has whole genome sequencing transformed the investigation of rare disease?
28th July 2023 in Genomics in practice /by Alison EmmThe way in which rare diseases are investigated has been opened up by whole genome sequencing. We look at its impact on both clinicians and patients
Pharmacogenomics: The future of preventing adverse drug reactions
23rd June 2023 in Genomics in practice /by Alison EmmIn the second part of our pharmacogenomics blog series, we look at how new research could lead to a more effective application of drugs
Genomic sequencing: A decade to a day
2nd June 2023 in Genomics in practice /by Alison EmmCuriosity, patience, and the humble pea plant are three fundamental factors that have allowed us to sequence an entire human genome in 24 hours
Developing people
for health and
healthcare
